Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

BUPIVACAINE HYDROCHLORIDE CRS(100 MG)

BUPIVACAINE HYDROCHLORIDE CRS(100 MG)

73360-54-0

DISCOVER
BUSERELIN CRS (12.18 MG)

BUSERELIN CRS (12.18 MG)

68630-75-1

DISCOVER
D-HIS-BUSERELIN CRS (0.5 MG)

D-HIS-BUSERELIN CRS (0.5 MG)

NA

DISCOVER
BUSULFAN CRS (50 MG)

BUSULFAN CRS (50 MG)

55-98-1

DISCOVER
BUTYLHYDROXYANISOLE CRS (60 MG)

BUTYLHYDROXYANISOLE CRS (60 MG)

25013-16-5

DISCOVER
BUTYLHYDROXYTOLUENE CRS (120 MG)

BUTYLHYDROXYTOLUENE CRS (120 MG)

128-37-0

DISCOVER
BUTYL PARAHYDROXYBENZOATE CRS(150 MG)

BUTYL PARAHYDROXYBENZOATE CRS(150 MG)

94-26-8

DISCOVER
IBUPROFEN IMPURITY B CRS (1.15 ML)

IBUPROFEN IMPURITY B CRS (1.15 ML)

NA

DISCOVER
Bisoprolol Hemifumarate

Bisoprolol Hemifumarate

104344-23-2

DISCOVER
Buflomedil HCl

Buflomedil HCl

35543-24-9

DISCOVER
Bisoctrizole

Bisoctrizole

103597-45-1

DISCOVER
Bamethane hemisulfate salt

Bamethane hemisulfate salt

5716-20-1

DISCOVER